Article: Addressing the shortage of QPs in the pharma industry
Posted: 10 June 2022 | NSF International | No comments yet
How the pharma industry can tackle the shortage of QPs by Lynne Byers, Senior Director Pharma Consulting, NSF Health Sciences.
The role of the Qualified Person (QP) is central to the pharmaceutical industry. Yet, of the 60,000+ people currently working in the industry, there are only 350 QPs in the UK. This shortage of talent presents limitations on the industry’s ability to perform clinical trials of new medicines and on the routine supply of commercial products. NSF explores three ways the pharmaceutical industry can tackle this skill shortage.
Related content from this organisation
Related topics
Biopharmaceuticals, Drug Delivery Systems, Good Manufacturing Practice (GMP), Manufacturing, QA/QC, Research & Development (R&D), Spectroscopy, Supply Chain, Vaccines
